Oxford Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
EHC
Oxford Asset Management's NVO Position: Q1 2020 in Review
Oxford Asset Management sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 11,326 shares — an estimated $328K sold.
Oxford Asset Management first reported a position in NVO in Q3 2013 and held it in 14 quarters. The position peaked at $7.49M in Q4 2016. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.
- Oxford Asset Management reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
- Oxford Asset Management sold 11,326 Novo Nordisk shares in Q1 2020, an estimated $328K.
- Oxford Asset Management first reported a position in Novo Nordisk in Q3 2013 and held it in 14 quarters.
- Oxford Asset Management's Novo Nordisk position peaked at $7.49M in Q4 2016.
- 644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.
Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.